Stephan Rogalla

Papers

Total Citations

139

H-Index

About

Stephan Rogalla is a leading figure in the development of molecular imaging agents for precision surgery, with a particular focus on fluorescence-guided surgery (FGS) and activatable contrast agents. His most influential work, the 2020 paper on "AND-gate contrast agents," has garnered 139 citations and represents a paradigm shift in intraoperative imaging. By engineering probes that require two distinct biological triggers—such as a specific enzyme and a low pH—before activating their fluorescent signal, Rogalla has dramatically improved the specificity of tumor margin detection. This "smart" approach minimizes background noise and false positives, enabling surgeons to distinguish malignant tissue from healthy tissue with unprecedented clarity. His contributions have been recognized with early-career awards and featured in high-impact journals, positioning him as a rising authority in theranostics and surgical oncology. Rogalla’s work not only advances the fundamental science of activatable probes but also directly addresses a critical clinical need: reducing incomplete resections and improving patient outcomes. For students and researchers, his research exemplifies how clever chemical design can bridge the gap between molecular biology and real-time surgical decision-making.